Experimental therapies target chronic lymphocytic leukemiaMonoclonal antibody and kinase inhibitor yield promising results in recent trials Will better treatment phase out breast screening?CNBSS 25-year results question mammography programs Results mixed for bevacizumab in glioblastoma Angiogenesis inhibitor fails to prolong overall survival Giotrif: new oral therapy for metastatic lung cancer Targeted treatment improves progression-free survival and disease related symptoms. Earlier access to palliative care teams helps patients with advanced cancer cope Study finds quicker access improves quality of life and satisfaction with care. Hormone therapy for breast cancer: When is five years enough? Ten-year treatment adds little benefit in early disease Prostate cancer treatment takes its toll Avoid over-treating and watch for complications, researcher says Unnecessary tests driving thyroid cancer epidemic Diagnosis rates vary widely but mortality remains constant Concern raised over stroke risk with aromatase inhibitors Manitoba registry turns up findings not seen in trials Chemo-trastuzumab tops in HER2-positive breast cancer Survival results are some of the best ever seen, researcher says First Previous 40 41 42 43 44 Next Last
